Golden
Cellular Dynamics International

Cellular Dynamics International

Cellular Dynamics International is a biotechnology company developing and manufacturing human cells used for drug discovery, toxicity testing, stem cell banking and cell therapy development.

Cellular Dynamics International is a biotechnology company headquartered in Madison, Wisconsin and was founded in 2004 by Craig T. January, Igor Slukvin, James A. Thomson, Robert J. Palay, Thomas M. Palay, and Timothy J. Kamp.

Acquired by Fujifilm

On march 30, 2015 Cellular Dynamics International was acquired by Fujifilm for $307 million. 

Funding

Series A

On November 24, 2008 Cellular Dynamics International completed their series A funding round with $18 million in funding from the Wisconsin Alumni Research Foundation and Tactics II Stem Cell Ventures. 

Series B

On April 27, 2010 Cellular Dynamics International completed their series B funding round with $40.6 million in funding from Tactics II Stem Cell Ventures (lead investor), Sixth Floor Investors, and Equity Group Investments. 

Series B preferred stock financing

On April 7, 2011 Cellular Dynamics International completed their series B preferred stock financing with $30 million in funding from Tactics II Stem Cell Ventures. 

Private equity funding round

On November 6, 2012 Cellular Dynamics International completed a private equity round raising $21 million in funding from Tactics II Stem Cell Ventures and Rose Ventures. 

Initial public offering (IPO)

On July 24, 2013 Cellular Dynamics International held an initial public offering (IPO) offering 3,846,000 shares of the company at $12 per share. The company raised a total of $43 million during their IPO. 



Timeline

July 24, 2013

Initial public offering (IPO)

On July 24, 2013 Cellular Dynamics International held an initial public offering (IPO) offering 3,846,000 shares of the company at $12 per share. The company raised a total of $43 million during their IPO. 

November 6, 2012

Private equity funding round

On November 6, 2012 Cellular Dynamics International completed a private equity round raising $21 million in funding from Tactics II Stem Cell Ventures and Rose Ventures. 

April 7, 2011

Series B preferred stock financing round

On April 7, 2011 Cellular Dynamics International completed their series B preferred stock financing with $30 million in funding from Tactics II Stem Cell Ventures. 

April 27, 2010

Series B funding round

On April 27, 2010 Cellular Dynamics International completed their series B funding round with $40.6 million in funding from Tactics II Stem Cell Ventures (lead investor), Sixth Floor Investors, and Equity Group Investments. 

November 24, 2008

Series A funding round

On November 24, 2008 Cellular Dynamics International completed their series A funding round with $18 million in funding from the Wisconsin Alumni Research Foundation and Tactics II Stem Cell Ventures. 

Funding rounds

2 Results
Funding round
Funding round
Funding round amount (USD)
Funding round amount (USD)
Funding type
Funding type
Funding round date
Funding round date
Investment
Investment

People

Name
Role
LinkedIn

Alex Wehrle

Employee



Anna Maria Swistowska

Employee



Gina Leaming

Employee



Gus Fuldner

Investor



Kwi Hye Kim

Employee



Marissa Stafford

Employee



Melissa Collins

Employee



Miles Lasater

Investor



nicole madfis

Employee



Pat Brooks

Employee



Robert Semmens

Investor



Thomas Novak

Employee



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References